Additionally, for the extended SGLT2 network, we observed enrichment in obesity, atherosclerosis and arteriosclerosis, breast cancer-related diseases, and Alzheimer’s disease. This evidence concerns the gene SLC5A2 and arteriosclerosis disorder.